Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis-Reference-Cited by-同舟云学术

Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis

Published:2020-04 Issue: Volume:133 Page:115221
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Yokomoto-Umakoshi Maki,Umakoshi Hironobu,Fukumoto Tazuru,Matsuda Yayoi,Nagata Hiromi,Ogata Masatoshi,Kawate Hisaya,Miyazawa Takashi,Sakamoto Ryuichi^ORCID,Ogawa Yoshihiro

Funder

Kyushu University

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference29 articles.

1. Vertebral fractures: clinical importance and management;Kendler;Am. J. Med.,2016

2. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline;Eastell;J. Clin. Endocrinol. Metab.,2019

3. Phaeochromocytoma;Lenders;Lancet,2015

4. Pheochromocytoma and paraganglioma;Neumann;N. Engl. J. Med.,2019

5. Cardiovascular manifestations of phaeochromocytoma;Prejbisz;J. Hypertens.,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Pheochromocytoma or Paraganglioma on Bone Metabolism: A Systemic Review and Meta-analysis;Journal of Clinical Densitometry;2024-07

2. Deteriorated bone microarchitecture caused by sympathetic overstimulation in pheochromocytoma and paraganglioma;Journal of Endocrinological Investigation;2023-10-24

3. Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas;Cancers;2023-09-21

4. New Insights in the Pathophysiology, Epidemiology, and Response to Treatment of Osteoporotic Vertebral Fractures;The Journal of Clinical Endocrinology & Metabolism;2023-05-15

5. Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess;Bone Reports;2022-12